Submissions

Login or Register to make a submission.

Author Guidelines

Instruction to authors

Authors should ensure that their manuscripts comply with the journal's submission and formatting requirements. Submissions that fail to meet these requirements may be returned for technical revision prior to peer review.

Manuscript category 

Original Research Article, Review Article, Systematic / Narrative Review, Short Communication, Case Report, Perspective / Commentary, Letter to the Editor, Study Protocol, Editorial (invited)

Preparation of Manuscripts

Prepared Manuscripts should be presented in one of the following formats:

Original Research Article

Original Research Articles report original, innovative, and scientifically significant research findings in pharmaceutical, biomedical, and allied sciences, etc. Manuscripts should be structured into Introduction, Materials and Methods, Results, Discussion, and Conclusion sections, with all conclusions supported by appropriate scientific evidence. The maximum length is 8,000 words, with up to 100 references, up to 10 figures or tables, a structured abstract (up to 250 words), and 3–6 keywords.

Review Article

Review Articles provide a comprehensive, balanced, and critical evaluation of recent advances in a specific area of research. They should summarize current knowledge, identify research gaps, and discuss future directions based on relevant scientific literature. Manuscripts may be up to 5,000 words, include a maximum of up to 100 references, 8 up to figures or tables, an abstract (up to 250 to 300 words), and 3–6 keywords.

Systematic / Narrative Review

Systematic Reviews should follow internationally recognized reporting guidelines such as PRISMA and include a clearly described methodology for literature identification, selection, and analysis. Narrative Reviews should provide an evidence-based overview of current literature with critical discussion and future perspectives. Manuscripts may be up to 6,000 words, with 120 references, up to 8 figures or tables, an abstract (up to 250 words), and 3–6 keywords.

Short Communication

Short Communications present novel findings, preliminary data, or innovative methodologies that are of immediate scientific interest but do not require a full-length research article. Manuscripts should be concise, with a maximum length of 2,500 words, 30 references, 3 figures or tables, an abstract (up to 150 words), and 3–6 keywords.

Case Report

Case Reports describe unusual, rare, or clinically significant cases that contribute valuable scientific or educational knowledge. Reports should include the clinical presentation, diagnosis, management, outcome, and a discussion of the case's significance. Manuscripts may be up to 3,000 words, include 30 references, 4 figures or tables, an abstract (up to 150 words), and 3–6 keywords.

Perspective / Commentary

Perspective or Commentary articles present expert opinions, emerging concepts, policy discussions, or viewpoints on current scientific developments. These articles should stimulate academic discussion and provide evidence-based perspectives rather than original research findings. Manuscripts may be up to 2,000 words, include 30 references, 3 figures or tables, and an abstract (up to 150 words).

Letter to the Editor

Letters to the Editor provide constructive comments on recently published articles or discuss topics of scientific interest relevant to the journal. They should be concise, evidence-based, and limited to 1,000 words, with up to 10 references and one figure or table, where necessary.

Study Protocol

Study Protocols describe the scientific rationale, objectives, methodology, study design, and statistical analysis plan for planned or ongoing studies prior to the availability of results. Protocols should follow appropriate reporting guidelines, such as SPIRIT for clinical trials. Manuscripts may be up to 4,000 words, include 50 references, 5 figures or tables, a structured abstract, and 3–6 keywords.

Editorial (Invited)

Editorials are generally commissioned by the Editor-in-Chief or Editorial Board and provide expert perspectives on current scientific issues, emerging research trends, or articles published in the journal. Editorials should be concise and limited to 1,500 words, with up to 10 references and, where appropriate, one author photograph or figure.

Manuscript Structure

1.   Title Page — full title (≤ 20 words), short running title, all author names with affiliations, ORCID iDs, corresponding author contact details.

2.   Structured Abstract — Background, Objective, Methods, Results, Conclusion, plus 4–6 keywords (preferably MeSH terms).

3.   Introduction — background, knowledge gap, and explicit study objective.

4.   Materials and Methods — sufficient detail for replication; ethics approval and registration numbers where applicable.

5.   Results — presented with appropriate statistical detail; tables/figures numbered in order of citation.

6.   Discussion — interpretation, comparison with existing literature, limitations.

7.   Conclusion — concise statement of the study's contribution.

8.   Declarations — Acknowledgements, Author Contributions (CRediT taxonomy), Conflict of Interest, Funding Statement, Data Availability Statement.

9.   References — Vancouver (numbered) style, in order of citation.

Formatting Specifications

 

Element

Requirement

File format

Editable .docx (Microsoft Word); figures as separate high-resolution .jpg/.jpeg/.tif/.png/.eps (min. 300 dpi)

Page setup

A4, 2.5 cm margins, double-spaced, continuous line numbering

Font

Times New Roman, 12 pt body text

Units

SI units throughout; generic (non-proprietary) drug names on first mention

Tables/Figures

Cited sequentially in text; self-explanatory captions; raw data available on request

Reference style

Vancouver / ICMJE numbered format

Similarity index

< 15% overall, < 3% from any single source (screened via plagiarism-detection software)

 

 

Submission Preparation Checklist

 

  • Cover letter confirming the originality of the manuscript and exclusive submission to this journal.
  • Title page with the full names, affiliations, ORCID IDs (where available), and complete contact details of all authors, submitted separately from the anonymized main manuscript.
  • Main manuscript prepared according to the Author Guidelines, including title, abstract, keywords, main text, references, tables, and figure legends.
  • Ethics Committee/Institutional Review Board (IRB) approval number for studies involving human participants or Animal Ethics Committee approval (in accordance with ARRIVE 2.0 and institutional guidelines), where applicable.
  • Clinical trial registration number, where applicable (WHO ICTRP-recognized registry or ClinicalTrials.gov).
  • Signed Authorship, Conflict of Interest, and Copyright/License Agreement forms from all listed authors.
  • Funding information and acknowledgements have been provided, where applicable.
  • Data Availability Statement included, where applicable.
  • AI-assisted writing or generative AI use has been disclosed, where applicable.
  • Permissions obtained for any reproduced copyrighted material (including tables, figures, images, or other third-party content).
  • All figures, tables, and supplementary files are complete, correctly numbered, and cited in the manuscript.
  • All references are formatted according to the journal style, and DOI numbers are included where available.
  • The manuscript has been checked for grammar, spelling, and plagiarism before submission.

Articles

Section default policy

Privacy Statement

The names, email addresses, and other personal information entered on this journal website will be used exclusively for the stated purposes of this journal and will not be shared with any third party or used for any other purpose without the user's consent, except where required by law. All personal information is handled in accordance with applicable data protection and privacy standards.